Globally, millions of people are affected by Alzheimer's disease, with around 120,000 individuals in Norway alone. Witnessing a loved one gradually decline because of this devastating condition can be ...

Even before a tumor in the pancreas becomes discernible, an activated cancer gene actively remodels its future environment ...

Biomarker tests analyze a patient's underlying biology to help clinicians diagnose disease, monitor progression and identify ...

A new Crispr-powered optical blood test detects lung cancer biomarkers at sub-attomolar levels, offering earlier molecular detection than conventional PCR or imaging.

FDA Will Drop Two-Study Requirement for New Drug Approvals, Aiming to Speed Access U.S News February 18, 2026 ...

What is the Market Size of Precision Medicine Research and Development Platform? The global market for Precision Medicine ...

Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain after treatment and are not detectable using conventional response criteria. In multiple myeloma, MRD ...

This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS ...

Upon exercise of the option and completion of the acquisition, AlphaTON would be entitled to an upfront cash payment at closing, equity consideration representing 10% of the fully diluted equity of ...

ZENTALIS® and its associated logo are trademarks of Zentalis and/or its affiliates. All website addresses and other links in this press release are for information only and are not intended to be an ...